Adam McAnaney
Known title: Chief Legal OfficerCIK: 0001842979
Associated companies
Transaction History
| OSCR | ▼ Sell | Open Market | 9,092 | $286K | 9/3/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 7,065 | $154K | 6/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 2,794 | $63K | 6/2/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 67,424 | $0 | 3/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 18,710 | $251K | 3/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 1,852 | $31K | 12/2/2025 | View on chart |
| OSCR | ▼ Sell | Tax Withholding | 1,845 | $31K | 9/2/2025 | View on chart |
| OSCR | ▼ Sell | Tax Withholding | 1,847 | $25K | 6/2/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 61,409 | $0 | 3/5/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 123,376 | $0 | 2/24/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.